SafeBridge Updates Potent API and Drug Manufacturer Status

News
Article

PTSM: Pharmaceutical Technology Sourcing and Management

PTSM: Pharmaceutical Technology Sourcing and ManagementPTSM: Pharmaceutical Technology Sourcing and Management-08-05-2015
Volume 11
Issue 8

SafeBridge Consultants reports on the status of nine companies in the Potent Compound Safety Certification Program.

SafeBridge Consultants has updated status of nine manufacturing organizations in the SafeBridge Potent Compound Safety Certification program, which is designed to assist pharmaceutical and biotechnology companies in identifying contract manufacturing organizations qualified in the safe handling of potent APIs and drug products.

The program offers drug innovators an independent assessment of the manufacturing company's capabilities for safe production of potent APIs and drug products. The program also provides pharmaceutical manufacturers with a metric to evaluate performance and to encourage continuous improvement.

SafeBridge Certification reports that the following organizations continue to maintain their effective performance in the recognition, evaluation, and control of potent compounds:

  • SAFC Commercial, Madison, WI;

  • SAFC Commercial, St. Louis, MO;

  • DSM Pharmaceuticals, Greenville, NC;

  • Novasep, Le Mans, France;

  • ScinoPharm, Tainan, Taiwan;

  • Excella, Feucht, Germany;

  • Albany Molecular Research Inc., Rensselaer, NY;

  • Baxter Oncology, Halle, Germany;

  • Corden Pharma, Boulder, CO; and

  • Pfanstiehl, Waukegan, IL.  

Certification is based on the successful implementation of a systematic approach to potent compound safety, including facility features, process equipment, and engineering controls; and programs, procedures, and practices. The on-site assessment includes evaluation of the physical plant features and equipment, as well as assessing occupational toxicology, industrial hygiene, safety, training, and medical surveillance programs, according to a SafeBridge statement.

A company is considered certified after an on-site assessment by two board-certified SafeBridge health professionals and achieving the minimum scoring requirements in program management, hazard evaluation, containment and controls and communication.

Source: SafeBridge Consultants

 

 

Recent Videos
Miguel Forte from ISCT and Kiji Therapeutics talks about the potential impact of a changing European political landscape.
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Mike Baird from Schlafender Haser discusses industry trends from 2024 and those expected to have an impact in 2025 from the perspective of a software developer.
Preeya Beczek from Beczek.COM gives her thoughts on the areas to watch with the new US administration and how Europe might be finalizing preparations for previous legislative changes
Related Content